Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
373
datasets available to search
ShareScore release 0.9.0
Dataset results
373 results for “Chronic myeloid leukemia”
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
ClinicalTrials.gov study NCT04883125. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00866736. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Chronic Myeloid Leukemia (CML) Real-Life Database
ClinicalTrials.gov study NCT05963061. IPD Sharing: NO. Countries: 1. Publications: 1.
A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation
ClinicalTrials.gov study NCT03883087. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
ClinicalTrials.gov study NCT00815321. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00028847. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
ClinicalTrials.gov study NCT00896129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
ClinicalTrials.gov study NCT01464411. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance
ClinicalTrials.gov study NCT01819389. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT03079505. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
ClinicalTrials.gov study NCT06119269. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
ClinicalTrials.gov study NCT02638467. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation
ClinicalTrials.gov study NCT04666259. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01613976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
ClinicalTrials.gov study NCT01627132. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02115295. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT06368414. IPD Sharing: NO. Countries: 0. Publications: 1.
Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT00510926. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase
ClinicalTrials.gov study NCT00514969. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Consolidation Treatment With Ponatinib 15 mg on Treatment Free-Remission Rate in Patients With Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT04043676. IPD Sharing: Not stated. Countries: 1. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.